General description
Cap B solution, containing tetrahydrofuran (THF), pyridine and N-methylimidazole (NMI), is mixed in situ with Cap A solution during the capping (acetylation) reaction. Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.Tetrahydrofurane has been replaced by acetonitrile in ÄKTA Cap B1 and B2.Cap B is configured for ÄKTA formulation.
Preparation Note
Acetonitrile / Pyridine 4/6 (v/v)
Other Notes
Cap B2 solution, containing acetonitrile (ACN) and pyridine, is mixed in situ with Cap A and Cap B1 solution during the capping (acetylation) reaction.
Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.
Legal Information
OligoPilot is a registered trademark of Cytiva
ÄKTA is a registered trademark of Cytiva
- UPC:
- 41113402
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- L050150-1.25L
akash.verma@cenmed.com
(732) 447-1115





